Sustaining Participation In A 20-Year Alzheimer's Family Study

Long-term clinical studies face a unique challenge: participant retention becomes more difficult as years pass and patient circumstances change. In Alzheimer's disease research, increasing mobility limitations, greater reliance on caregivers, and the burden of repeated site visits can significantly impact participation, placing valuable longitudinal data at risk.

A family-based Alzheimer's study designed to follow participants for up to 20 years demonstrates how decentralized research approaches can help overcome these barriers. By incorporating home-based study visits conducted by clinical research clinicians, participants are able to continue contributing to research even when traveling to a study site becomes impractical. This flexible model supports continuity throughout the study lifecycle, helping maintain engagement across geographically dispersed populations while reducing participant burden. The results highlight the critical role of patient-centric trial designs in preserving retention, supporting protocol adherence, and safeguarding the long-term data needed to advance understanding of neurodegenerative disease.

Discover how home visits can transform long-term follow-up strategies and strengthen study success.